Replimune Group, Inc. (NASDAQ:REPL) Receives $10.00 Average Price Target from Brokerages
Shares of Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) have earned an average recommendation of “Hold” from the ten research firms that are currently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and six have assigned a buy […]
30 Mar 08:48 · The Markets Daily